US 7052691
Methods of treating diabetes by blocking VEGF-mediated activity
granted A61KA61K38/00A61P
Quick answer
US patent 7052691 (Methods of treating diabetes by blocking VEGF-mediated activity) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/00, A61P, A61P15/00, A61P3/00